DUBLIN, Nov. 4, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/ccrh25/2016_us) has announced the addition of the "2016 US Diagnostics Market: Blood Banking, Cancer, Coagulation, Flow Cytometry, Hematology, Immunodiagnostics, Microbiology, Molecular Diagnostics--Supplier Shares, Competitive Strategies, Volume and Sales Segment Forecasts for 300 Tests" report to their offering.
This new report provides an overview of the US diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments:
- Blood Banking
- Cancer
- Chemistry
- Coagulation
- Drugs of Abuse
- Endocrine
- Hematology and Flow Cytometry
- Immunoprotein
- Infectious Diseases
- Molecular Diagnostics
- TDM
Table of Contents
Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Reimbursement
4. Industry Consolidation
5. Managed Care
a. PPO
b. HMO
6. Hospitals
7. Admissions
8. Length of Stay
9. Industry Diversification
10. Physician Demographics
11. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
12. Laboratory Regulations
13. FDA Reform
Market Structure 1. Centralized Testing a. Hospitals b. Commercial/Private Laboratories c. Blood Banks 2. POC/Decentralized Testing a. Ambulatory Care Centers b. Cancer Clinics c. Home/Self Testing d. Physician Offices/Group Practices e. Other Decentralized Testing Locations
For more information visit http://www.researchandmarkets.com/research/ccrh25/2016_us
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets
Share this article